Clinical Trial

BEAT-SHOCK Registry

Study acronym: BEAT-SHOCK
Recruiting
View on ClinicalTrials.gov →
Summary
This regulation defines the purpose, the operational processes, and the organization of the registry BEAT-SHOCK (Basel Evaluation of Acute Therapy in cardiogenic SHOCK). It describes the requirements for collecting, storing, processing, managing and sharing health-related registry data.
Trial Details
NCT Number NCT07643610
Lead Sponsor University Hospital, Basel, Switzerland
Conditions Cardiogenic Shock, Myocardial Infarction (MI), Fulminant Myocarditis, Acute Decompensated Heart Failure, Severe Valvular Disease, Post-cardiotomy, Perioperative Cardiogenic Shock
Enrollment 8,000 participants
Start Date 2025-10-01
Primary Completion 2035-10-01 (estimated)
Study Completion 2035-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-11